Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

4D Molecular Therapeutics Inc (FDMT)

4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

4D Molecular Therapeutics Inc 5858 HORTON STREET #455 EMERYVILLE CA 94608 USA

www.4dmoleculartherapeutics.com Employees: 227 P: 510-505-2680

Sector:

Medical

Description:

4D Molecular Therapeutics Inc. is a clinical-stage gene therapy company which develops product candidates using its targeted and evolved adeno-associated viruses vectors. It offers a portfolio of gene therapy product candidates focusing on the ophthalmology, cardiology and pulmonology therapeutic areas. 4D Molecular Therapeutics Inc. is based in Emeryville, California.

Key Statistics

Overview:

Market Capitalization, $K 435,369
Enterprise Value, $K 286,029
Shares Outstanding, K 57,135
Float, K 51,650
% Float 90.40%
Short Interest, K 8,678
Short Float 15.19%
Days to Cover 5.89
Short Volume Ratio 0.56
% of Insider Shareholders 9.60%
% of Institutional Shareholders 99.27%

Financials:

Annual Sales, $ 40 K
Annual Net Income, $ -160,870 K
Last Quarter Sales, $ 90 K
Last Quarter Net Income, $ -56,880 K
EBIT, $ -230,390 K
EBITDA, $ -232,920 K

Growth:

1-Year Return 64.67%
3-Year Return -63.83%
5-Year Return -81.85%
5-Year Revenue Growth -99.43%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.01 on 11/10/25
Next Earnings Date 02/27/26
Earnings Per Share ttm -3.75
EPS Growth vs. Prev Qtr -3.06%
EPS Growth vs. Prev Year -27.85%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

FDMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.27%
Return-on-Assets % -42.39%
Profit Margin % -402,175.00%
Debt/Equity 0.00
Price/Sales 3,579.75
Price/Cash Flow N/A
Price/Book 0.96
Book Value/Share 7.90
Interest Coverage -2.45
60-Month Beta 2.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar